Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion type Assertion NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_head.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion evidence source_evidence_literature NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion SIO_000772 11037980 NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion wasDerivedFrom befree-20140225 NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.
- NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_assertion wasGeneratedBy ECO_0000203 NP275748.RAl4_NvOScXt52CNYtMgrhRBSE-ZRpZy8LgGK7rU9KsFk130_provenance.